
Upgrades
For Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the first quarter, Agile Therapeutics had an EPS of $3.78, compared to year-ago quarter EPS of $8.00. The stock has a 52-week-high of $4.37 and a 52-week-low of $0.11. At the end of the last trading period, Agile Therapeutics closed at $0.50.